STOCK TITAN

Fuse Group Stock Price, News & Analysis

FUST OTC Link

Company Description

Fuse Group Holding Inc. (FUST) is a Nevada-incorporated company whose common stock trades on the OTCQB market under the symbol FUST. According to available disclosures, the company has described itself as being in development of business in the mining and biotech areas and has also engaged in consulting, marketing and business development activities.

Business focus and activities

In a public announcement from Arcadia, California, Fuse Group Holding Inc. stated that it is a company in development of business in the mining and biotech areas. This indicates that the company has pursued opportunities related to mineral resources and biotechnology, while also exploring additional lines of business.

The company reported that it agreed to provide general consulting, marketing and business development services to Beijing Jixiang Fengqi Tech Company Limited, an IT consulting and digital marketing services firm. Under this relationship, Fuse Group’s role includes marketing research, competitive analysis and digital marketing implementation to support Beijing Jixiang’s efforts to expand and grow its business in the North American market.

Fuse Group Holding Inc. has also disclosed activity in the biotech area through a wholly owned subsidiary, Fuse Biotech Inc. The company reported entering into a non-binding letter of intent to acquire all equity interests of E-Mo Biotech Holding Inc., a Nevada corporation involved in biology research and development. E-Mo’s work, as described in that announcement, includes vaccines, immunological treatment, diagnostic product development and similar treatments against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and relevant diseases.

According to the same disclosure, E-Mo has been involved in applying with the U.S. Food and Drug Administration for a phase 4 clinical trial for a new intended use of an existing vaccine, the polio vaccine, against SARS-CoV-2 in the control and prevention of Coronavirus disease (COVID-19). Fuse Group characterized this potential acquisition as part of its strategy to enter the biotech research and development area.

Consulting and marketing services

In addition to its mining and biotech development focus, Fuse Group Holding Inc. has publicly discussed its intention to diversify its business and tap resources into new growth areas. The consulting agreement with Beijing Jixiang Fengqi Tech Company Limited reflects this direction, with Fuse Group agreeing to support Beijing Jixiang’s North American market expansion through consulting, marketing and business development services.

The company has indicated that its consulting work for Beijing Jixiang includes activities such as marketing research, competitive analysis and digital marketing implementation. These activities position Fuse Group as a service provider to a third-party IT consulting and digital marketing company that seeks to grow outside its home market.

Corporate structure and governance

Fuse Group Holding Inc. is incorporated in Nevada and has reported its Commission File Number as 333-202948 and its IRS Employer Identification Number as 47-1017473 in an 8-K filing. In that same filing, the company reported that it had no securities registered under Section 12(b) of the Securities Exchange Act of 1934 and that no class of its securities was listed on a national securities exchange.

The company has disclosed changes in its board of directors. In an 8-K report, Fuse Group stated that a member of its board of directors submitted a resignation, and that the board expanded its size and appointed two new directors. The filing also provided background information on the new directors, including their prior work experience and educational history, and stated that there were no family relationships between the new directors and any director or executive officer of the company.

Regulatory and trading context

Fuse Group Holding Inc. reports to the U.S. Securities and Exchange Commission (SEC) under its Nevada incorporation. The company has filed current reports on Form 8-K to disclose material events such as changes in its board of directors. It has also identified that it does not have securities registered on a national securities exchange, and its common stock trades on the OTCQB market under the symbol FUST.

Business development orientation

Across its public statements, Fuse Group Holding Inc. has emphasized development and diversification. It has described itself as a company in development of business in the mining and biotech areas, while also highlighting efforts to enter the biotech research and development area through potential acquisition activity. At the same time, the consulting agreement with Beijing Jixiang Fengqi Tech Company Limited illustrates a focus on consulting, marketing and business development services for clients seeking to expand their presence in North America.

According to statements from company leadership in its news releases, Fuse Group views cooperation with partners such as Beijing Jixiang as a way to attract more business opportunities. This reflects an orientation toward using consulting and marketing capabilities to support both its own growth and the growth of its counterparties.

Industry classification

For sector classification purposes, Fuse Group Holding Inc. is associated with the manufacturing sector and has been categorized under tobacco manufacturing. At the same time, its own public communications emphasize mining and biotech business development, as well as consulting and marketing services, indicating that its activities span multiple areas as described in its announcements.

Stock Performance

$—
0.00%
0.00
Last updated:
-53.58%
Performance 1 year

Fuse Group (FUST) stock last traded at $0.1240. Over the past 12 months, the stock has lost 53.6%. At a market capitalization of $1.6M, FUST is classified as a micro-cap stock with approximately 13.3M shares outstanding.

FUST Rankings

Latest News

Fuse Group has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all FUST news →

SEC Filings

Fuse Group has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on February 12, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FUST SEC filings →

Financial Highlights

Fuse Group generated $46K in revenue over the trailing twelve months, retaining a 100.0% gross margin. Diluted earnings per share stood at $-0.02. With a current ratio of 0.11, short-term liquidity bears monitoring.

$46K
Revenue (TTM)
$46K
Gross Profit (TTM)
Net Income (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FUST Company Profile & Sector Positioning

Fuse Group (FUST) operates in the Other Industrial Metals & Mining industry within the broader Basic Materials sector and is listed on the OTC Link.

Investors comparing FUST often look at related companies in the same sector, including Gamma Resources (MLLOF), Jaxon Mng (JXMNF), Champion Bear (CBRSF), Canada Rare (RAREF), and Cascadero Copper (CCEDF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FUST's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Fuse Group (FUST)?

The current stock price of Fuse Group (FUST) is $0.124 as of April 17, 2026.

What is the market cap of Fuse Group (FUST)?

The market cap of Fuse Group (FUST) is approximately 1.6M. Learn more about what market capitalization means .

What is the revenue (TTM) of Fuse Group (FUST) stock?

The trailing twelve months (TTM) revenue of Fuse Group (FUST) is $46K.

What is the earnings per share (EPS) of Fuse Group (FUST)?

The diluted earnings per share (EPS) of Fuse Group (FUST) is $-0.02 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the gross margin of Fuse Group (FUST)?

The gross profit margin of Fuse Group (FUST) is 100.0%. Learn about gross margins.

What is the current ratio of Fuse Group (FUST)?

The current ratio of Fuse Group (FUST) is 0.11, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Fuse Group (FUST)?

The gross profit of Fuse Group (FUST) is $46K on a trailing twelve months (TTM) basis.

What does Fuse Group Holding Inc. do?

According to its public statements, Fuse Group Holding Inc. is a company in development of business in the mining and biotech areas and has also engaged in consulting, marketing and business development services for other companies.

How is Fuse Group Holding Inc. involved in biotech?

Fuse Group Holding Inc., through its wholly owned subsidiary Fuse Biotech Inc., reported entering into a non-binding letter of intent to acquire E-Mo Biotech Holding Inc., a Nevada company involved in biology research and development, including vaccines, immunological treatment, diagnostic product development and similar treatments against SARS-CoV-2 and relevant diseases.

What is the relationship between Fuse Group Holding Inc. and Beijing Jixiang Fengqi Tech Company Limited?

Fuse Group Holding Inc. announced that it signed a consulting agreement with Beijing Jixiang Fengqi Tech Company Limited, under which Fuse Group agreed to provide general consulting, marketing and business development services, including marketing research, competitive analysis and digital marketing implementation, to help Beijing Jixiang expand and grow its business in the North American market.

On which market does Fuse Group Holding Inc. trade?

Fuse Group Holding Inc. has stated that its common stock trades on the OTCQB market under the symbol FUST. In an SEC filing, the company also reported that it has no securities registered on a national securities exchange under Section 12(b) of the Securities Exchange Act of 1934.

What is E-Mo Biotech Holding Inc. and how is it connected to Fuse Group Holding Inc.?

E-Mo Biotech Holding Inc. is described by Fuse Group Holding Inc. as a Nevada company involved in biology research and development, including vaccines, immunological treatment, diagnostic product development and similar treatments against SARS-CoV-2 and relevant diseases. Fuse Group reported entering into a non-binding letter of intent to acquire all equity interests of E-Mo through its subsidiary Fuse Biotech Inc.

How has Fuse Group Holding Inc. described its strategy in biotech?

In its announcement about the letter of intent with E-Mo Biotech Holding Inc., Fuse Group Holding Inc. stated that the potential acquisition would implement the company’s strategy of entering into the biotech research and development area and contribute to efforts to control the COVID-19 pandemic through research and development.

What corporate governance changes has Fuse Group Holding Inc. reported?

In a Form 8-K filing, Fuse Group Holding Inc. reported that a member of its board of directors submitted a resignation and that the board expanded its size and appointed two new directors. The filing included background information on the new directors and stated that there were no family relationships between them and any director or executive officer of the company.

Where is Fuse Group Holding Inc. incorporated?

Fuse Group Holding Inc. reported in its SEC filings that it is incorporated in the state of Nevada and identified its Commission File Number as 333-202948 and its IRS Employer Identification Number as 47-1017473.

How does Fuse Group Holding Inc. describe its diversification efforts?

In its news release about the consulting agreement with Beijing Jixiang Fengqi Tech Company Limited, Fuse Group Holding Inc. stated that it is looking to diversify its business and tap more resources into new growth, and that cooperation with Beijing Jixiang may help the company attract more business opportunities.